Month: September 2024

AI in Networks Market worth $46.8 Billion by 2029, at a CAGR of 33.8%

“AI in Networks Market”
The global AI in Networks Market in terms of revenue is estimated to be worth $10.9 billion in 2024 and is poised to reach $46.8 billion by 2029, growing at a CAGR of 33.8% during the forecast period.

The report “AI in Networks Market by Offering (Router & Switches, AI Networking Platform, Management Software, Software Defined Networking), Function (Optimization, Cybersecurity, Predictive Maintenance), Technology (Gen AI, ML, NLP) – Global Forecast to 2029” The global AI in Networks market is expected to be valued at USD 10.9 billion in 2024 and is projected to reach USD 46.8 billion by 2029 and grow at a CAGR of 33.8% from 2024 to 2029.

The growing adoption of 5G, IoT, connected devices, and advanced security solutions creates new avenues for AI in network applications. Advanced cybersecurity systems are being utilized to identify real-time threat detection. The heightened focus on cybersecurity drives the demand for AI in the networks market.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131514910

Browse 153 market data Tables and 63 Figures spread throug 235 Pages and in-depth TOC on “AI in Networks Market”

View detailed Table of Content here – https://www.marketsandmarkets.com/Market-Reports/ai-in-networks-market-131514910.html

AI in Networks Market

The AI in networks market for AI networking platforms will hold the highest CAGR during the forecast period.

AI networking platform is expected to hold the highest CAGR during the forecast period. The growth is primarily driven by the demand for a single platform to automate network management tasks. The platform uses AI and ML technology to identify anomalies, manage traffic, and increase operational efficiency while minimizing errors. It also detects equipment failures by analyzing historical data for scheduled maintenance. Additionally, AI networking platforms work efficiently with existing infrastructure and ensure infrastructure interoperability without the need for new hardware and software.

The AI in networks market for Gen AI technology to hold the highest CAGR during the forecast period

The AI in networks market for Gen AI technology is expected to grow at the highest CAGR during the forecast period. Gen AI helps telecom operators optimize network resource distribution, enabling the efficient operation of telecom services. It also helps predict equipment failure patterns based on historical data to schedule maintenance and minimize downtime. Additionally, Gen AI helps telecom operators manage and optimize vast traffic data to detect potential fraud and security breaches. Telecom operators can use Gen AI in networks to secure their network operations and customer data.

The AI in networks market for the data center end-use industry is expected to hold the highest CAGR during the forecast period.

The AI in networks market for the data centers end-use industry is expected to hold the highest CAGR during the forecast period. Data centers utilize AI-driven networking solutions for resource management, such as dynamic bandwidth allocation, computing power, and storage. This helps data centers reduce operational costs and increase performance. Additionally, AI-driven networks help automate various network management tasks in data centers, from system updates to traffic routing. These factors contribute to the significant demand for AI network solutions in data centers.

The AI in networks market for Asia Pacific to hold the highest CAGR during the forecast period

The AI in networks market in the Asia Pacific region is expected to hold the highest CAGR during the forecast period. Rapid industrialization, technological advancements, and significant growth in internet and mobile penetration primarily drive the growth in Asia Pacific. Countries like China, Japan, India, and South Korea are investing heavily in digital infrastructure developments in the region. Additionally, various countries in the region have AI strategies in place, offering investment, regulatory support, and incentives for the development of AI-driven network solutions.

Key Players

The AI in networks Market Market includes significant Tier I and II players like NVIDIA Corporation, Cisco Systems, Inc. (US), Telefonaktiebolaget LM Ericsson (Sweden), Hewlett Packard Enterprise Development LP (US), Arista Networks, Inc. (US), and others. These players have a strong market presence for AI in networks across various North America, Europe, Asia Pacific, and RoW countries.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103
City: Delray Beach
State: FL 33445
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/ai-in-networks-market-131514910.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: AI in Networks Market worth $46.8 Billion by 2029, at a CAGR of 33.8%

Hepatic Tumor Treatment Drugs, Clinical Trials, Pipeline Insights, and Companies 2024

DelveInsight’s, “Hepatic Tumor Pipeline Insight 2024”report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in Hepatic Tumor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Explore our latest breakthroughs in Hepatic Tumor Research. Learn more about our innovative pipeline today! @ Hepatic Tumor Pipeline Outlook

 

Key Takeaways from the Hepatic Tumor Pipeline Report

  • In September 2024:- Biotheus Inc.- A Phase Ib/II Clinical Trial to Evaluate the Preliminary Efficacy, Safety and Pharmacokinetics of PM8002 Injection Combined With PM1009 Injection in Patients With Locally Advanced or Metastatic Hepatocellular Carcinoma.
  • In September 2024:- AstraZeneca- The purpose of this study is to measure the efficacy and safety of durvalumab intravenous (IV) solution plus bevacizumab IV solution after transarterial radioembolization (Yttrium 90 glass microspheres TARE) in participants with unresectable hepatocellular carcinoma (HCC) amenable to embolization.
  • DelveInsight’s Hepatic Tumor pipeline report depicts a robust space with 75+ active players working to develop 75+ pipeline therapies for Hepatic Tumor treatment.
  • The leading Hepatic Tumor Companies such as Can Fite Biopharma, MiNA Therapeutics, Medivir AB, Janssen Research & Development, LLC, Etnova Therapeutics Corp., SillaJen Biotherapeutics, Akeso Biopharma, Shanghai Junshi Biosciences, Genmab/Janssen Biotech, Bio-Thera Solutions, Ocuphire Pharma, Surface Oncology, Genoscience, Onyx Pharmaceuticals, Qurient Co., Ltd., Kowa Company, Ltd., Eureka Therapeutics Inc., and others.
  • Promising Hepatic Tumor Therapies such as Atezolizumab, Bevacizumab 15 mg/kg, Tiragolumab, Zimberelimab, Domvanalimab, and others.

 

Stay informed about the cutting-edge advancements in Hepatic Tumor Treatments. Download for updates and be a part of the revolution in cancer care @ Hepatic Tumor Clinical Trials Assessment

 

Hepatic Tumor Emerging Drugs Profile

  • Namodenoson: Can Fite Biopharma

Namodenoson is a small molecule A3 adenosine receptor (A3AR) agonist. It is an oral drug currently being developed for the treatment of oncology diseases including advanced liver cancer(hepatocellular carcinoma), pancreatic cancer and metabolic associated steatohepatitis (MASH). Currently it is in Phase III stage of clinical trial evaluation to treat Hepatocellular Carcinoma.

  • MTL CEBPA : MiNA Therapeutics

MTL-CEBPA is a novel medicine being developed as a combination therapy in cancer. MTL-CEBPA is designed to reduce immune suppression of myeloid cells by restoring C/EBP-a protein to normal levels using the RNA Activation mechanism. The drug candidate uses the RNA interference mechanism of action. Currently being evaluated in the Phase II studies for the treatment of Hepatic Tumor.

  • Amivantamab: Janssen Research & Development, LLC

Amivantamab is a fully-human EGFR-MET bispecific antibody with immune cell-directing activity that targets tumors with activating and resistance EGFR mutations and MET mutations and amplifications. The drug is based on antibody-dependent cell cytotoxicity mechanism of action. The drug is in Phase II stage of clinical trials for the treatment of Hepatic Tumor.

  • Fostroxacitabine bralpamide: Medivir AB

Fostroxacitabine bralpamide is a small molecule a type of smart chemotherapy that delivers the cell-killing compound selectively to the tumor while minimizing the harmful effect on normal cells. being developed by Medivir AB. It works as Nucleotide DNA polymerase inhibitor. The drug candidate is administered through oral route. Currently the drug is being evaluated in Phase I/II for the treatment of Hepatic Tumor.

  • ETN101: Etnova Therapeutics Corp.

ETN101 is a synthetic drug candidate designed to be a best-in-class anticancer agent targeting hepatocellular carcinoma. It is being developed with the aim of preoccupying the market for both first-line and follow-up treatments of hepatocellular carcinoma with its high rate of complete remission and safety. It inhibits protein activity using FLT3/KIT/VEGFR2/PDGFRB tyrosine kinase inhibitors and its downstream signaling pathways: PI3K/AKT and RAS-MAPK, working as multiple tyrosine kinase inhibitors (mTKI). The drug is in Phase I stage of clinical trials for the treatment of Hepatic Tumor.

 

Learn more about Hepatic Tumor Drugs opportunities in our groundbreaking Hepatic Tumor Research and development projects @ Hepatic Tumor Unmet Needs

 

Hepatic Tumor pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.

  • Oral
  • Parenteral
  • intravenous
  • Subcutaneous
  • Topical.

 

Hepatic Tumor Products have been categorized under various Molecule types such as

  • Monoclonal Antibody
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy

 

Discover the latest advancements in Hepatic Tumor Treatment by visiting our website. Stay informed about how we’re transforming the future of Oncology @ Hepatic Tumor Market Drivers and Barriers, and Future Perspectives

 

Scope of the Hepatic Tumor Pipeline Report

  • Coverage- Global
  • Hepatic Tumor Companies- Can Fite Biopharma, MiNA Therapeutics, Medivir AB, Janssen Research & Development, LLC, Etnova Therapeutics Corp., SillaJen Biotherapeutics, Akeso Biopharma, Shanghai Junshi Biosciences, Genmab/Janssen Biotech, Bio-Thera Solutions, Ocuphire Pharma, Surface Oncology, Genoscience, Onyx Pharmaceuticals, Qurient Co., Ltd., Kowa Company, Ltd., Eureka Therapeutics Inc., and others.
  • Hepatic Tumor Therapies- Atezolizumab, Bevacizumab 15 mg/kg, Tiragolumab, Zimberelimab, Domvanalimab, and others.
  • Hepatic Tumor Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Hepatic Tumor Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

 

For a detailed overview of our latest research findings and future plans, read the full details of Hepatic Tumor Pipeline on our website @ Hepatic Tumor Drugs and Companies

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Hepatic Tumor: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Late Stage Products (Phase III)
  7. Comparative Analysis
  8. Namodenoson: Can Fite Biopharma
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. MTL CEBPA : MiNA Therapeutics
  12. Early Stage Products (Phase I)
  13. Comparative Analysis
  14. ETN101: Etnova Therapeutics Corp.
  15. Inactive Products
  16. Hepatic Tumor Key Companies
  17. Hepatic Tumor Key Products
  18. Hepatic Tumor – Unmet Needs
  19. Hepatic Tumor – Market Drivers and Barriers
  20. Hepatic Tumor – Future Perspectives and Conclusion
  21. Hepatic Tumor Analyst Views
  22. Hepatic Tumor Key Companies
  23. Appendix

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Hepatic Tumor Treatment Drugs, Clinical Trials, Pipeline Insights, and Companies 2024

Behavior Analytics Market Growth Opportunities, Business Scenario, Share, Growth Size, Scope, Key Segments And Forecast To 2029

“Qualtrics (US), OpenText (Canada), Microsoft. (US), Cisco Systems, Inc. (US), IBM (US), Zoho Corporation (India), Oracle (US), Varonis Systems, Inc. (US), Fortinet, Inc. (US), Securonix (US), Teradata (US), Google (US), Adobe (US), SAS Institute (US), Qlik (US).”
Behavior Analytics Market by Solutions (User and Entity Behavior, A/B Testing, Heatmap, Feedback & Voice of Customer), Application (Customer Engagement, Brand Promotion, Workforce Optimization, Threat Detection & Prevention) – Global Forecast to 2029.

The global behavior analytics market is expected to expand from USD 5.5 billion in 2024 to USD 13.4 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 19.5%. A key factor driving this growth is the increasing demand for advanced security solutions to detect and prevent insider threats and fraud. Additionally, companies are leveraging behavior analysis to gain deeper insights into user actions, enabling personalized services and enhancing customer experiences. The rapid adoption of cloud-based services and the integration of AI and machine learning technologies are also fueling the market’s expansion across various industries.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106193738  

Behavior analytics is a surging functionality that has immense significance in the betterment of cybersecurity and operational efficiency. It empowers organizations to identify the anomaly, insider threat, and probable fraud by harnessing the power of user and entity behavior analytics. Similarly, as business enterprises gradually adopt higher-level technology Al and machine learning behavior analytics solutions also increase in terms of accuracy and adaptability. This allows the maturing of security postures, reduction of operational risks, and the making of data-driven decisions in pacing up to the threats that are rapidly morphing. The market is segmented on the basis of offering, type, application, and vertical. Offering includes solutions like user and entity behavior, A/B testing, Feedback and voice of the customer (VOC), Heatmap among other solutions like session replay, website conversion optimization. This further can be divided into customer-centric and employee-centric. Applications in this segment involve customer engagement, brand promotion, workforce optimization, threat detection, and prevention applications, many more of which get further categorized into applications like personalized recommendations, product development, and compliance management. The verticals segment includes BFSI, Retail & Ecommerce, Telecom, IT & ITES, Media & Entertainment, Healthcare, Government & Defense, Travel & Hospitality, and Other verticals, which include Transportation & Logistics and Energy & Utilities. These together provide a composite, deep view into the evolving landscape of behavioral analytics and its likely business implications.

“Based on application, customer engagement segment to hold the largest market size during the forecast period.”

Customer engagement would have the largest market size during the forecast period, owing to the fact that this segment potentially might register high growth by enhancing and personalizing customer interactions. Enterprises are leveraging behavior analytics to develop rich insights into customer preferences, purchasing habits, and interaction patterns. It therefore allows business organizations to come up with highly targeted marketing strategies, to base most of their offerings on the needs of customers, and to improve the quality of service. On the other hand, this better satisfies and creates more loyalty among customers, which again turns into more efficient strategies of customer engagement and retention. Coupled with this, the delivery of customized experiences that would be carried out in a way that would give a differentiating edge over their peers, especially with regard to closer ties with customers, has increased demand for behavior analytics solutions in the customer engagement space.

“Based on offering, the service segment is expected to hold a higher growth rate during the forecast period.”

The service segment is bound to grow at a higher rate in the forecast period, as more demand arises for support and expertise to deploy and manage behavior analytics solutions. In contrast to product-based offerings, services are comprehensive in nature, where implementation and customization, continuous support would be required to use such behaviour analytics tools to their full functionality by organizations. Consequently, the business starts striving to adopt these solutions in their existing system and optimally tunes them for its needs; therefore, increasing demand for professional consulting, training, and technical support. On the whole, behavior analytics solutions are complex in nature and require special kinds of knowledge and are always in a phase of maintenance in order to fight off threats and problems of businesses.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=106193738  

Unique Features in the Behavior Analytics Market

One of the standout features of the behavior analytics market is its role in enhancing security. By analyzing user behavior, organizations can detect unusual patterns, helping to identify and mitigate insider threats, fraud, and other malicious activities before they cause significant damage.

Another unique aspect is the ability to provide companies with a deeper understanding of user actions. By tracking and analyzing behavior patterns, organizations can tailor their services to meet individual customer preferences, improving the overall user experience.

The rapid adoption of cloud-based services is a notable trend in the behavior analytics market. Cloud platforms offer scalability, flexibility, and cost-effectiveness, making it easier for businesses to implement behavior analytics tools.

A key feature driving innovation in the behavior analytics market is the integration of artificial intelligence (AI) and machine learning (ML) technologies. These technologies enhance the ability of behavior analytics tools to process vast amounts of data, identify patterns, and make real-time decisions. This integration allows businesses to predict potential risks and automate responses, further strengthening security and operational efficiency.

Behavior analytics is not limited to one specific sector; its applications are broad and versatile across various industries, including finance, healthcare, retail, and manufacturing. This adaptability ensures that behavior analytics remains a critical tool for improving customer experience, enhancing security, and optimizing business processes in diverse markets.

Major Highlights of the Behavior Analytics Market

A major highlight of the market is its critical role in strengthening cybersecurity. Organizations are increasingly leveraging behavior analytics to detect insider threats, fraud, and other security breaches.

The behavior analytics market is also being fueled by the growing need for companies to understand user behavior at a granular level. By doing so, businesses can deliver personalized services, which in turn improves customer satisfaction and engagement.

The market is seeing a surge in the adoption of cloud-based behavior analytics solutions. Cloud platforms enable organizations to scale operations efficiently and offer cost-effective solutions. The flexibility and ease of integration with existing systems make cloud-based services a significant driver of the behavior analytics market’s expansion.

The integration of artificial intelligence (AI) and machine learning (ML) is revolutionizing the behavior analytics market. These technologies enhance data processing, allowing for more accurate and real-time predictions. As businesses increasingly adopt AI/ML-driven analytics, they gain better insights into behavior trends and automated responses, leading to greater operational efficiency and security.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=106193738  

Top Companies in the Behavior Analytics Market

Key and innovative vendors in the behavior analytics market include Qualtrics (US), OpenText (Canada), and Microsoft. (US), Cisco Systems, Inc. (US), IBM (US), Zoho Corporation (India), Oracle (US), Varonis Systems, Inc. (US), Fortinet, Inc. (US), Securonix (US), Teradata (US), Google (US), Adobe (US), SAS Institute (US), Qlik (US), 84.51˚ (US), Contentsquare (France), Exabeam (US), Clevertap (US), Dtex Systems (US), Mouseflow (US), Gurucul (US), Netspring (US), Visier, Inc. (Canada), Teramind (US), SplashBI (US), Amplitude (US), Prohance (India). The market players have adopted various strategies to strengthen their market position. Organic and inorganic strategies have helped the market players expand globally by providing a comprehensive suite of behavior analytics solutions, boosting innovation through research and development initiatives, establishing strategic partnerships with key industry stakeholders, and facilitating mergers and acquisitions to strengthen their technological capabilities and market presence.

Qualtrics

Qualtrics is an American experience management company based in Seattle, Washington, and Provo, Utah and established in 2002 among the founders Scott M. Smith, Ryan Smith, Jared Smith, and Stuart Orgill. It was launched with concerns on experience management in March 2017. Currently, the Company has 20 offices in 5 clusters of the world. From December 2023, Qualtrics had approximately 5,600 employees working worldwide. Leading the marketplace in behavior analytics, Qualtrics combines next-generation technology with customer obsession and is investing heavily in this regard of late.

This will increase the already AI-driven platform of the company for more enhanced experience management. Treating customer feedback with sensitivity, Qualtrics placed its services at the top rung in experience management with constant iteration of the services at hand in hand, serving a gamut of customers from thousands of global organizations.

OpenText

OpenText Corporation is an information management company headquartered in Waterloo, Ontario, Canada. The company was established in 1991 with the objective of offering information-based solutions to businesses across the globe. Some of its most important products are Enterprise Content Management, Digital Process Automation, AI and Analytics, and Business Network Solutions. The geographic span of OpenText extends to over 60 countries around the globe, with locations in North America, Europe, Asia-Pacific, Middle East, and Africa. With nearly 24,100 employees around the world, OpenText has become one of the leaders in the information management space through its innovative products that help organizations sharpen their businesses and, therefore, accelerate their transformation into nimbler digital organizations.

OpenText consistently maintains its leadership in behavior analytics by making strategic acquisitions to support a strong product line for the changing business demands. It has overlaid new analytics features into its existing platforms, which are said to help firms drive valuable insights from their data. The next suite of analytics firms the company acquired enhanced OpenText to increase its AI and analytics capabilities with the likes of Micro Focus, bettering data-driven decisions for customers. This makes OpenText a trusted partner in the corporate world for handling complex digital transformations and connecting operationally to behavior analytics.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103
City: Delray Beach
State: FL 33445
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/behavior-analytics-market-106193738.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Behavior Analytics Market Growth Opportunities, Business Scenario, Share, Growth Size, Scope, Key Segments And Forecast To 2029

Surgical Robots Market Forecast to Grow at 17.6% CAGR from 2024 to 2031 | SkyQuest Technology

“Surgical Robots Market”
The Surgical Robots Market exceeded USD 5.2 billion in 2023 and is anticipated to grow at a CAGR of 17.6% from 2024 to 2031.

The Surgical Robots Market exceeded USD 5.2 billion in 2023 and is anticipated to grow at a CAGR of 17.6% from 2024 to 2031.

The growing burden on the healthcare industry and the dearth of skilled surgeons around the world are projected to boost the demand for surgical robots over the coming years. Advancements in robotic technologies and growing investments in the development of novel surgical robots are also expected to create new opportunities for surgical robot companies in the future. 

Increasing acceptance of robotic surgeries and growing realization regarding the benefits of robotic surgeries are also estimated to favor sales of surgical robots across the study period. Surgical robot companies should explore the use of advanced technologies to create more accurate and effective surgical robots to maximize their business scope in the future. 

 

Get a Free Sample Research Report:https://www.skyquestt.com/sample-request/surgical-robots-market

 

Segmentation Analysis:

By Component Robot Systems, Instruments and Accessories

By Application Orthopedic Surgery, Neurosurgery, General Surgery, Gynecology Surgery, Urologic Surgery, Others

By End-user Hospitals, Ambulatory Surgical Centers (ASCs)

By Regions North America , Europe , Germany, Asia Pacific , Latin America

 

Developing Novel Surgical Robots with Advanced Technologies Remains the Top Priority for All Market PlayersThe global surgical robots’ market is highly opportune as digitization picks up pace in the global healthcare landscape. Surging investments in the development of novel healthcare automation solutions will create new opportunities for surgical robot providers. Integration of artificial intelligence and machine learning will also open new avenues of opportunities for surgical robot’s market players in the long run. Collaborations can help surgical robot providers reduce their R&D time and improve the potential of commercialization as well. Creating awareness regarding the perks of robotic surgeries and their high accuracy will also be crucial in boosting market growth going forward.  

  • In June 2024, Think Surgical and Zimmer Biomet joined hands to exclusively distribute a knee surgery robot. The companies would build upon Think’s existing robotic device for knee surgery applications and customize it to make it more suitable for outpatient use. 
  • In June 2024, the third generation of India’s surgical robotic system SSI Mantra 3 was launched by SS Innovations. The company backed this launch with the impressive feat of completing a human trial telesurgery, which was the first of its kind in India.
  • A surgical robot for knee replacement surgeries to make them more affordable and accessible was launched in India in June 2024. Meril, a medical device company from India was behind the launch of this new indigenously developed robot and it also claimed that the robot has a 98% success rate in its operation.
  • In February 2024, a miniature surgical robot designed by a robotics start-up called Virtual Incision performed simulated surgical operations at the International Space Station (ISS). The robot was remotely controlled by surgeons on Earth.  

 

 

Ask for Customization: https://www.skyquestt.com/speak-with-analyst/surgical-robots-market

 

Key players:

  • Corin Group (OMNILife Science, Inc.)
  • Globus Medical Inc.
  • Transenterix (Asensus Surgical, Inc.)
  • Intuitive Surgical
  • Smith and Nephew
  • Siemens Healthlineers
  • Renishaw Plc
  • Johnson & Johnson
  • Microsure
  • Brainlab AG
  • Medtronic (Mazor Robotics)
  • Stryker
  • Distalmotion
  • THINK Surgical Inc.
  • Zimmer Biomet

 

This report covers the following segments:

  1. A. Component
  2. Robot Systems
  3. Instruments
  4. Accessories
  5. B. Application
  6. Orthopedic Surgery
  7. Neurosurgery
  8. General Surgery
  9. Gynecology Surgery
  10. Urologic Surgery

 

View report summary and Table of Contents (TOC): https://www.skyquestt.com/report/surgical-robots-market

 

Utilizing advanced technologies and adding more autonomy to surgical robots will help surgical robot providers cement their place in the future of healthcare. Investing in the development of novel robots with advanced technologies will be highly crucial for almost all companies operating in the global surgical robots’ market. Collaborating with robotic technology providers could help surgical robot companies gain a competitive advantage over other market players in the long run.

Visit Our Website: https://www.skyquestt.com/

Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email: Send Email
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/surgical-robots-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Surgical Robots Market Forecast to Grow at 17.6% CAGR from 2024 to 2031 | SkyQuest Technology

Head and Neck Cancer Clinical Trials, Pipeline Insights, Treatment Drugs, and Companies 2024

DelveInsight’s, “Head and Neck Cancer Pipeline Insight 2024” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Head and Neck cancer pipeline landscape. It covers the Head and Neck Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Head and Neck Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Discover the latest drugs and treatment options in the Head and Neck Cancer Pipeline. Dive into DelveInsight’s comprehensive report today! @ Head and Neck Cancer Pipeline Outlook

 

Key Takeaways from the Head and Neck Cancer Pipeline Report

  • In September 2024:- Alentis Therapeutics AG- The purpose of this study is to evaluate the safety profile of ALE.C04 monotherapy and in combination with pembrolizumab, to characterize pharmacokinetics profile of ALE.C04, recommended Phase II dose (RP2D) for ALE.C04 in combination with pembrolizumab and as monotherapy and to assess anti-tumor activity of ALE.C04 monotherapy and in combination with pembrolizumab in patients with Head and Neck Cancer.
  • In August 2024:- GlaxoSmithKline- The primary purpose of the study is to evaluate the antitumor activity and safety of novel immunotherapy combinations compared with dostarlimab in participants with Programmed death ligand 1 (PD-L1) positive Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC).
  • DelveInsight’s Head and Neck Cancer pipeline report depicts a robust space with 80+ active players working to develop 160+ pipeline therapies for Head and Neck Cancer treatment.
  • The leading Head and Neck Cancer Companies such as Debiopharm, Merck, GlaxoSmithKline, QBiotics Group Limited, Memgen, Inc., BioNTech, Alentis Therapeutics AG, Beijing CorreGene Biotechnology, Coordination Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Sichuan Baili Pharmaceutical Co., Ltd., TILT Biotherapeutics Ltd., Coherus Biosciences, Inc., and others.
  • Promising Head and Neck Cancer Therapies such as RiMO-301, Pembrolizumab, Dostarlimab, Belrestotug, Nelistotug, Methotrexate, Afatinib, and others.

 

Stay ahead with the most recent pipeline outlook for Head and Neck Cancer. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Head and Neck Cancer Treatment Drugs

 

Head and Neck cancer Emerging Drugs

  • Xevinapant: Debiopharm/Merck
  • Dostarlimab: GlaxoSmithKline
  • Tigilanol tiglate: QBiotics Group Limited
  • MEM-288: Memgen, Inc.

 

Explore groundbreaking therapies and clinical trials in the Head and Neck Cancer Pipeline. Access DelveInsight’s detailed report now! @ New Head and Neck Cancer Drugs

 

Head and Neck cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration

  • Oral
  • Intravenous
  • Subcutaneous
  • Parenteral
  • Topical

 

Head and Neck Cancer Products have been categorized under various Molecule types such as

  • Monoclonal Antibody
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy

 

Unveil the future of Head and Neck Cancer Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight’s expert analysis @ Head and Neck Cancer Market Drivers and Barriers

 

Scope of the Head and Neck Cancer Pipeline Report

  • Coverage- Global
  • Head and Neck Cancer Companies- Debiopharm, Merck, GlaxoSmithKline, QBiotics Group Limited, Memgen, Inc., BioNTech, Alentis Therapeutics AG, Beijing CorreGene Biotechnology, Coordination Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Sichuan Baili Pharmaceutical Co., Ltd., TILT Biotherapeutics Ltd., Coherus Biosciences, Inc., and others.
  • Head and Neck Cancer Therapies- RiMO-301, Pembrolizumab, Dostarlimab, Belrestotug, Nelistotug, Methotrexate, Afatinib, and others.
  • Head and Neck Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Head and Neck Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

 

Get the latest on Head and Neck Cancer Therapies and clinical trials. Download DelveInsight’s in-depth pipeline report today! @ Head and Neck Cancer Companies, Key Products and Unmet Needs

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Head and Neck Cancer: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Late Stage Products (Phase III)
  7. Xevinapant: Debiopharm/Merck
  8. Drug profiles in the detailed report…..
  9. Mid Stage Products (Phase II)
  10. Tigilanol tiglate: QBiotics Group Limited
  11. Drug profiles in the detailed report…..
  12. Early Stage Products (Phase I)
  13. MEM-288: Memgen, Inc.
  14. Drug profiles in the detailed report…..
  15. Preclinical and Discovery Stage Products
  16. Drug name: Company name
  17. Drug profiles in the detailed report…..
  18. Inactive Products
  19. Head and Neck Cancer Key Companies
  20. Head and Neck Cancer Key Products
  21. Head and Neck Cancer – Unmet Needs
  22. Head and Neck Cancer – Market Drivers and Barriers
  23. Head and Neck Cancer – Future Perspectives and Conclusion
  24. Head and Neck Cancer Analyst Views
  25. Head and Neck Cancer Key Companies
  26. Appendix

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Head and Neck Cancer Clinical Trials, Pipeline Insights, Treatment Drugs, and Companies 2024

The Global Pressure Washer Market to Hit $3.96 Billion in the Next 6 Years: Market Size, Share, & Competitive Analysis 2023-2029 – Arizton

“Pressure Washer Market Research Report by Arizton”

 

According to Arizton’s latest research report, the global pressure washer market is growing at a CAGR of 4.32% during 2023-2029.

   

Looking for More Information? Click: https://www.arizton.com/market-reports/pressure-washer-market-report

 

Report Scope:   

Market Size (2029): $3.96 Billion       

Market Size (2023): $3.07 Billion       

CAGR (2023-2029): 4.32%        

Historic Year:  2020-2022           

Base Year: 2023           

Forecast Year: 2024-2029           

Market Segmentation: Pressure Washer type, Power Source, Operation, Output, End-User, Residential End-User, Commercial & Industrial End-User, Distribution Channel, and Geography

Geographical Analysis: North America, Europe, APAC, Latin America, and Middle East & Africa   

   

Book the Free Sample Now: https://www.arizton.com/market-reports/pressure-washer-market-report

 

The global pressure washer market is dynamic bustling with competition and innovation. With major players like Kärcher, Nilfisk, FNA Group, Robert Bosch, and Briggs & Stratton vying for consumer attention, the stakes are high. As technology evolves at a breakneck pace, customers increasingly expect cutting-edge features and upgrades, pushing vendors to refine their offerings to stand out.

Pressure washers have carved a niche across various applications—from sprucing up homes and vehicles to maintaining industrial equipment and agricultural settings. For instance, farmers rely on these machines to keep their equipment and livestock areas spotless.

The market is intricately segmented by product type, power source, and application, each revealing distinct growth patterns and consumer preferences. Electric pressure washers, known for their user-friendliness and quieter operation, are top-rated in residential settings.

Regionally, growth is fueled by rising investments in business, a surge in commercial and residential construction, government initiatives to improve infrastructure, and an expanding hospitality sector driven by tourism. Demand varies significantly by region, shaped by local economic conditions and consumer habits. For example, a strong DIY culture in North America boosts the appetite for pressure washers.

Amidst this evolving landscape, vendors must continually innovate and adapt, striving to deliver unique value propositions that resonate with an ever-demanding market.

 

 

Key Development

  • Briggs & Stratton introduced Quiet Sense technology that reduces noise emissions by 40% compared to a standard pressure washer engine, which runs at constant speed. Quiet Sense technology reduces the noise of idle operations. As soon as the spray gun is released, the engine drops to a lower speed, minimizing the decibel levels emitted. Some other major pressure washers with moderate noise levels include Nilfisk C-PG 130.2, Husqvarna PW 235 & 360, STIHL RE 129 Plus, STIHL RE 130 Plus, and AVA Master P60.
  • Kärcher has launched the K4 Silent Home electric pressure washer that claims to produce 50% lower noise levels and is equipped with a powerful machine that can operate at a pressure of 1900 PSI. The machine has one of the highest pressure volumes compared to other electric pressure washers, which is preferred over gas-powered pressure washers.

 

Key Vendors

  • Robert Bosch
  • Briggs & Stratton
  • Kärcher
  • Nilfisk
  • FNA Group 
  • Generac Power Systems
  • Annovi Reverberi
  • Lavorwash
  • Alkota
  • Snow Joe
  • IPC (Integrated Professional Cleaning)
  • Koblenz
  • Koki Holdings
  • Makita
  • Vortex Industries
  • Snap-on
  • DuroMax
  • AVA of Norway
  • RIDGID
  • WEN Products
  • Westinghouse
  • ANLU
  • Mi-T-M
  • Yamaha
  • Deere & Company
  • STIHL
  • Techtronic Industries (TTI)
  • SIMONIZ
  • BE Power Equipment
  • Northern Tools+Equipment
  • Greenworks
  • Husqvarna

 

 

Electric Power Source Leading the Market

In 2023, the electric pressure washer market made waves with a valuation of $1,530.53 million, poised to reach an impressive by 2029.

One of the standout features of electric pressure washers is their lightweight design, making them highly portable. Despite their nimble frame, some models boast formidable power, exceeding 2,500 PSI, and come equipped with various attachments to customize pressure settings for different tasks. Operating at an average noise level of 78 dB, they offer a quieter alternative to their gas-powered counterparts, aligning with a growing preference for more environmentally friendly options. Without fuel, these electric machines contribute to sustainability, replacing hydrocarbons with cleaner energy sources.

The versatility of electric pressure washers shines through their multiple operational modes, allowing users to adjust power levels to suit specific cleaning needs. However, the dependency on a nearby power outlet can be a limitation. To enhance user experience, vendors are encouraged to offer extension cords, providing greater flexibility during operation.

Maintenance is another area where electric models excel. With fewer parts that require frequent replacement and no ongoing costs for gas or oil, they present a cost-effective choice. However, the power cord can restrict maneuverability, which is a consideration for users.

Key players in the electric pressure washer market include Kärcher, RYOBI, Bosch, Stanley Black & Decker, AR Blue Clean, and Briggs & Stratton, each contributing to the innovation and appeal of this growing segment. As environmental consciousness shapes consumer preferences, electric pressure washers are well-positioned to lead the charge in sustainable cleaning solutions.

 

Segmentation & Forecast

 

Pressure Washer Type

  • Mobile
  • Stationery

 

Power Source

  • Electric
  • Gas
  • Battery
  • Others

 

Operation

  • Hot Water
  • Cold Water

 

Output

  • 0-1,500 PSI
  • 1,501-3,000 PSI
  • 3,001-4,000 PSI
  • Above 4,000 PSI

 

End-users

  • Residential
  • Gardens
  • Vehicles
  • Swimming Pools & Large Patio Areas
  • Bicycles
  • Others
  • Commercial & Industrial
  • Automobile
  • Construction
  • Public & Municipality
  • Retail
  • Hospitality
  • Healthcare
  • Agriculture
  • Others
  • Contract Cleaners

 

Distribution Channel

  • Offline
  • Online

 

Geography

  • Europe
  • Germany
  • The U.K.
  • France
  • Denmark
  • Sweden
  • Italy
  • Spain
  • North America
  • The U.S.
  • Canada
  • APAC
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Thailand
  • Latin America
  • Brazil
  • Mexico
  • Columbia
  • Chile
  • Argentina
  • Middle East & Africa
  • The GCC
  • Turkey
  • South Africa
  • Egypt

 

In a nutshell, the Arizton Advisory & Intelligence market research report provides valuable market insights for industry stakeholders, investors, researchers, consultants, and business strategists aiming to gain a thorough understanding of the pressure washer market. Request for Free Sample to get a glance of the report now: https://www.arizton.com/market-reports/pressure-washer-market-report

 

What Key Findings Will Our Research Analysis Reveal? 

How big is the global pressure washer market?

Which region dominates the global pressure washer market?

What is the growth rate of the global pressure washer market?

Who are the major global pressure washer market players?

What are the key drivers of the global pressure washer market?

 

Looking for Customization According to Your Business Requirement? https://www.arizton.com/customize-report/4489

 

Other Related Reports that Might be of Your Business Requirement 

Global Drain Cleaner Market – Focused Insights 2024-2029

The global drain cleaner market is projected to reach USD 3.08 billion by 2029, growing at a CAGR of 5.93% during the forecast period. Explore! https://www.arizton.com/market-reports/drain-cleaner-and-disinfectant-market-size-analysis

Global Carpet Cleaner Market – Focused Insights 2024-2029

The global carpet cleaner market is projected to reach USD 1.49 billion by 2029, growing at a CAGR of 4.65% during the forecast period. Learn more about the market: https://www.arizton.com/market-reports/carpet-cleaner-market-global-industry-analysis-report

 

Why Arizton?                                            

100% Customer Satisfaction                                            

24×7 availability – we are always there when you need us                                            

200+ Fortune 500 Companies trust Arizton’s report                                            

80% of our reports are exclusive and first in the industry                                            

100% more data and analysis                                            

1500+ reports published till date                          

               

Post-Purchase Benefit                                        

  • 1hr of free analyst discussion                                        
  • 10% off on customization                     

              

About Us:                                                                                 

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                                               

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                                                

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.                                                                                      

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1-312-235-2040/ +1 302 469 0707      
Country: United States
Website: https://www.arizton.com/market-reports/pressure-washer-market-report

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Global Pressure Washer Market to Hit $3.96 Billion in the Next 6 Years: Market Size, Share, & Competitive Analysis 2023-2029 – Arizton

Stargardt Disease Clinical Trials, Pipeline Insights, Treatment Drugs, and Companies 2024

DelveInsight’s, “Stargardt Disease Pipeline Insight, 2024,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Stargardt Disease (STGD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Discover the latest drugs and treatment options in the Stargardt Disease Pipeline. Dive into DelveInsight’s comprehensive report today! @ Stargardt Disease Pipeline Outlook

 

Key Takeaways from the Stargardt Disease Pipeline Report

  • In August 2024:- Belite Bio Inc.- A Phase 1b Open-label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Tinlarebant in Japanese Subjects With Stargardt Disease and a Phase 2/3 Randomized, Double-masked, and Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Tinlarebant in Subjects With Stargardt Disease.
  • DelveInsight’s Stargardt Disease pipeline report depicts a robust space with 20+ active players working to develop 20+ pipeline therapies for Stargardt Disease treatment.
  • The leading Stargardt Disease Companies such as Belite Bio, Ocugen, Alkeus Pharmaceuticals, Astellas Pharma, SalioGen Therapeutics, Ascidian, Biogen, Splice Bio, and others.
  • Promising Stargardt Disease Therapies such as OCU410ST, Tinlarebant, ALK-001, ACDN-01, avacincaptad pegol, and others.

 

Stay ahead with the most recent pipeline outlook for Stargardt Disease. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Stargardt Disease Treatment Drugs

 

Stargardt Disease Emerging Drugs Profile

  • Tinlarebant: Belite Bio

Tinlarebant is a novel oral therapy that is intended to reduce the accumulation of vitamin A-based toxins (known as bisretinoids) that cause retinal disease in STGD1 and also contribute to disease progression in GA, or advanced Dry AMD. Bisretinoids are by-products of the visual cycle, which is dependent on the supply of vitamin A (retinol) to the eye. Tinlarebant works by reducing and maintaining levels of serum retinol binding protein 4 (RBP4), the sole carrier protein for retinol transport from the liver to the eye. By modulating the amount of retinol entering the eye, Tinlarebant reduces the formation of bisretinoids. Tinlarebant has been granted Fast Track Designation and Rare Pediatric Disease designation in the US, and Orphan Drug Designation in the U.S., Europe, and Japan for the treatment of STGD1. Currently, the drug is in Phase III stage of its clinical trial for the treatment of Stargardt disease.

  • KIO-301: Kiora Pharmaceuticals

KIO-301 is a molecular photoswitch designed to confer light-sensing capabilities to Retinal Ganglion Cells (RGCs). It targets patients with inherited retinal diseases where mutations lead to photoreceptor death, causing vision loss. Unlike healthy eyes where photoreceptors perform light detection, KIO-301 selectively enters RGCs downstream of degenerated photoreceptors. Inside RGCs, it interacts with voltage-gated ion channels. When exposed to light, KIO-301 changes shape, altering current flow and activating neurons to signal the brain. Removal of light causes KIO-301 to revert to its original shape, halting signaling. Essentially, KIO-301 acts as a light switch within the eye, restoring light sensitivity in patients with retinal degeneration. Currently, the drug is in Phase II stage of its clinical trial for the treatment of stargardt disease.

  • OCU410: Ocugen

OCU410 utilizes an AAV delivery platform for the retinal delivery of the RORA (RAR Related Orphan Receptor A) gene. The RORA protein plays an important role in lipid metabolism, reducing lipofuscin deposits and oxidative stress, and demonstrates an anti-inflammatory role in-vitro and in-vivo (animal model) studies. These results demonstrate the ability for OCU410 to target multiple pathways linked with dAMD pathophysiology. Ocugen is developing AAV-RORA as a one-time gene therapy for the treatment of GA. Currently, the drug is in Phase I/II stage of its clinical trial for the treatment of stargardt disease.

 

Explore groundbreaking therapies and clinical trials in the Stargardt Disease Pipeline. Access DelveInsight’s detailed report now! @ New Stargardt Disease Drugs

 

Stargardt disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration

  • Oral
  • Parenteral
  • Intravenous
  • Subcutaneous
  • Topical

 

Stargardt Disease Products have been categorized under various Molecule types such as

  • Recombinant fusion proteins
  • Small molecule
  • Monoclonal antibody
  • Peptide
  • Polymer
  • Gene therapy

 

Unveil the future of Stargardt Disease Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight’s expert analysis @ Stargardt Disease Market Drivers and Barriers

 

Scope of the Stargardt Disease Pipeline Report

  • Coverage- Global
  • Stargardt Disease Companies- Belite Bio, Ocugen, Alkeus Pharmaceuticals, Astellas Pharma, SalioGen Therapeutics, Ascidian, Biogen, Splice Bio, and others.
  • Stargardt Disease Therapies- OCU410ST, Tinlarebant, ALK-001, ACDN-01, avacincaptad pegol, and others.
  • Stargardt Disease Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Stargardt Disease Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

 

Get the latest on Stargardt Disease Therapies and clinical trials. Download DelveInsight’s in-depth pipeline report today! @ Stargardt Disease Companies, Key Products and Unmet Needs

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Stargardt Disease: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Stargardt disease – DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. Tinlarebant: Belite Bio
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. KIO-301: Kiora Pharmaceuticals
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I/II)
  14. OCU410: Ocugen
  15. Drug profiles in the detailed report…..
  16. Preclinical and Discovery Stage Products
  17. Drug name: Company name
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Stargardt disease Key Companies
  21. Stargardt disease Key Products
  22. Stargardt disease -Unmet Needs
  23. Stargardt disease -Market Drivers and Barriers
  24. Stargardt disease -Future Perspectives and Conclusion
  25. Stargardt disease Analyst Views
  26. Stargardt disease Key Companies
  27. Appendix

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Stargardt Disease Clinical Trials, Pipeline Insights, Treatment Drugs, and Companies 2024

Tax Management Market Latest Trends, Size, Share, Future Growth, Industry Analysis, Advance Technology And Forecast – 2027

“Thomson Reuters (Canada), Intuit (US), H&R Block (US), Avalara (US), Wolters Kluwer NV (Netherlands), Automatic Data Processing (US), Sovos Compliance (US), SAP SE (Germany), Blucora (US), Vertex (US), DAVO Technologies (US), Sailotech (US), Defmacro Software (India), Xero (New Zealand).”
Tax Management Market by Component (Software and Services), Deployment Mode (Cloud and On-Premises), Tax Type (Indirect Tax and Direct Tax), Organization Size (SMEs and Large Enterprises), Vertical and Region – Global Forecast to 2027.

The global tax management market is projected to grow from USD 21.0 billion in 2022 to USD 35.1 billion by 2027, with a Compound Annual Growth Rate (CAGR) of 10.8% over the forecast period.

Key factors driving this market growth include the continuous rise in digital financial transactions and transformations, increasing complexity of tax regulations, the growing adoption of emerging technologies for tracking taxpayers, and stringent government tax collection policies. These factors present lucrative opportunities and improved service delivery prospects throughout the forecast period.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=230446693  

Software segment to continue with the larger market size during the forecast period

Tax management software facilitates the completion of tax returns for companies operating across verticals. It provides automated tax compliance with local accounting legislation and standards. Organizations across the globe have started adopting tax management software to keep up with the rapidly changing regulations and shifts in product taxability. Tax management software is experiencing an increasing demand pertaining to the ever-evolving tax and accounting laws across countries. There has to be enhanced software that can consider all of the regulatory needs and compliances put forward by the authorities of various regions. This is of utmost importance and provides alert(s) while establishing tax obligations across regions, and countries based on their nexus laws.

SMEs to record a higher CAGR during the forecast period

The increasing complexity of tax compliance has forced SMEs to adopt advanced tax management software. Cost-effectiveness is an important need for SMEs, as limited budgets always constrain them. This, in turn, leads to restricted ways adopted by SMEs to market themselves and gain visibility. SMEs have come a long way in enhancing strategic approaches including, but not limited to, service offerings, filing and reporting compliance requirements, levels of tax understanding, tax obligations complexity, and rapid changes in business ecosystems/environments. For instance, IRS (Internal Revenue Service) estimates that businesses with less than USD 1 million in revenue are to incur almost two-thirds of business compliance costs. Such costs are larger, related to revenues or assets, for SMEs than for large enterprises. Additionally, due to the complex tax codes, SMEs can understate their revenues and overstate their expenses, thus underpaying their taxes.

Manufacturing vertical to hold the second-highest market size during the forecast period

Manufacturing firms are an integral part of the supply/value chain. Hence, manufacturing firms must run smoothly so that the value chain will be stable. Globalization, eCommerce, and product shipment have reduced the gap between manufacturers and consumers. Nowadays, manufacturers have extended their market reach, resulting in more revenue and increased taxable products and services. The challenges faced while calculating tax for a manufacturer include selling to retailers or resellers, product-wise taxability, shipping or delivery, installation, and repairs. Hence, the process of tax calculation is complex and needs continuous observation. Manufacturers need to pay fines for any missing or invalid certificate. Tax management solutions can greatly help manufacturers better handle exempt or taxable transactions. Avalara and ClearTax are some of the companies providing tax management solutions to manufacturing companies.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=230446693  

Unique Features in the Tax Management Market

One of the standout features of the tax management market is the growing complexity of tax laws and regulations. As governments implement more intricate tax policies, businesses are compelled to adopt advanced tax management solutions to ensure compliance.

The market is also being shaped by the rapid digitalization of financial transactions. With businesses increasingly conducting operations online, tax management solutions are evolving to handle large volumes of digital transactions across multiple platforms.

Another unique feature driving the tax management market is the integration of innovative technologies such as artificial intelligence (AI), blockchain, and machine learning (ML). These technologies enhance the ability to track taxpayer activities, automate tax calculations, and improve the accuracy of tax filing and reporting.

The enforcement of strict government tax collection policies is another defining characteristic of this market. Governments around the world are increasingly adopting stringent regulations and oversight mechanisms to ensure compliance and reduce tax evasion.

The combination of growing tax complexity, digital transactions, and technological advancements is creating significant opportunities for enhanced service delivery in the tax management market.

Major Highlights of the Tax Management Market

This rapid growth underscores the increasing demand for advanced tax management solutions as businesses seek to navigate the complexities of tax regulations and digital financial transactions.

A key highlight is the increasing complexity of tax rules and regulations, which is pushing companies to adopt sophisticated tax management systems. As tax laws become more intricate and vary across regions, organizations need efficient tools to ensure compliance and avoid potential legal issues.

The ongoing shift towards digital financial transactions is another major driver in the market. As businesses expand their online operations and embrace digital payment systems, the volume of financial data to be processed has increased exponentially.

The adoption of cutting-edge technologies such as artificial intelligence (AI), machine learning (ML), and blockchain is revolutionizing tax management. These technologies are enhancing automation, improving accuracy in tax reporting, and offering predictive insights into tax liabilities.

The introduction of stricter government tax collection policies and compliance mandates is a prominent factor driving market demand. Governments are enforcing more rigorous tax regulations to increase transparency and reduce evasion, leading businesses to invest in reliable tax management solutions.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=230446693  

Top Companies in the Tax Management Market

The tax management market comprises major providers, such as Thomson Reuters (Canada), Intuit (US), H&R Block (US), Avalara (US), Wolters Kluwer NV (Netherlands), Automatic Data Processing (US),  Sovos Compliance (US), SAP SE (Germany), Blucora (US), Vertex (US), DAVO Technologies (US), Sailotech (US), Defmacro Software (India), Xero (New Zealand), TaxSlayer (US), TaxCloud (US), Drake Enterprises (US), Canopy Tax (US), TaxJar (US), Webgility (US), Taxback International (Ireland), LOVAT Software (UK), SafeSend (US), EXEMPTAX (US), Sales Tax DataLINK (US), SAXTAX (US,) and Shoeboxes (US).

Intuit :

Starting with Intuitwas founded in 1984 and is headquartered in California, US. The company offers financial management and compliance solutions and services. Small businesses and self-employed, consumer, and strategic partners are the three business partners of the company. QuickBooks, TurboTax, Mint, Credit Karma, ProSeries, and Lacerte are the specialized products of Intuit. It has offices in countries including the US, Canada, India, Israel, Australia, and the UK. The consumer segment includes products and services such as TurboTax, TurboTax Online, and TurboTax Live. Lacerte, ProSeries, ProFile desktop, and ProConnect Tax Online are its flagship products and services in the strategic partner segment. Intuit offers its solutions in both ways, online and desktop. The online offerings are also accessible on mobile devices, enabling users to utilize services at any time from a mobile location.

Thomson Reuters :

founded in 2008 and headquartered in Toronto, Canada, offers news and information-based tools to organizations and professionals globally. In a strategic partnership with The Blackstone Group Inc, Thomson Reuters sold its 55% stake in the Financial & Risk (F&R) business for about USD 17 billion and restructured its business by introducing new consumer-focused segments. It operates through three business segments: Recurring, Transactions, and Global print. The tax professionals segment serves tax, accounting, and audit firms. The corporate segment includes corporate customers and offers them a full suite of offerings. The company provides its tax and accounting solutions to accounting firms, corporations, financial institutions, governments, and law firms. Thomson Reuters offers its tax and accounting solutions in more than 15 countries across North America, Latin America, Europe, the Middle East & Africa, and Asia Pacific regions.

Wolters Kluwer :

Founded in 1968 and headquartered in Alphen aan den Rijn in the Netherlands. The company is a leading provider of software solutions and services for professionals belonging to tax, finance, audit, healthcare, risk, compliance, and regulatory sectors. It operates through segments including digital and service subscriptions, print subscriptions, transactions, and legal and financial services, among others. It serves customers from more than 180 countries across the globe. It has 93% of Fortune 500 companies as its clients. Tax and accounting is a leading contributor segment in the company’s revenue. According to its 2021 results, it generated 79% Recurring Revenues. The company reported revenues up 6% to USD 6.3 billion, organic revenues up by 5%, and included solutions for compliance, collaboration, internal and external audit management, corporate performance management, and firm management. Accounting firms, corporate finance, tax and auditing departments, and government agencies are some of the major customers of tax management solutions provided by the company. It has operations in 40 countries across the globe.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103
City: Delray Beach
State: FL 33445
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/tax-management-market-230446693.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Tax Management Market Latest Trends, Size, Share, Future Growth, Industry Analysis, Advance Technology And Forecast – 2027

Triple Negative Breast Cancer Clinical Trials, Treatment Drugs, Pipeline Insights, and Companies 2024

DelveInsight’s, “Triple Negative Breast Cancer Pipeline Insight 2024” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Triple Negative Breast Cancer pipeline landscape. It covers the Triple Negative Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Discover the latest drugs and treatment options in the Triple Negative Breast Cancer Pipeline. Dive into DelveInsight’s comprehensive report today! @ Triple Negative Breast Cancer Pipeline Outlook

 

Key Takeaways from the Triple Negative Breast Cancer Pipeline Report

  • In September 2024:- Merck Sharp & Dohme LLC- A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician’s Choice (TPC) in Participants With Triple-Negative Breast Cancer (TNBC) Who Received Neoadjuvant Therapy and Did Not Achieve a Pathological Complete Response (pCR) at Surgery
  • DelveInsight’s Triple Negative Breast Cancer Pipeline analysis depicts a robust space with 75+ active players working to develop 80+ pipeline treatment therapies.
  • The leading Triple Negative Breast Cancer Companies working in the market include Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 Therapeutics, Inc., Infinity Pharmaceuticals, HiberCell, Inc., Zenith Epigenetics, BioLite, Inc., Abbisko Therapeutics, Phoenix Molecular Designs, OncoTherapy Science, ModernaTX, Inc, and others.
  • Promising Triple Negative Breast Cancer Pipeline Therapies in the various stages of development include Nanosomal Docetaxel Lipid Suspension (75 mg/m2), Taxotere® (100 mg/m2), B013+Nab-Paclitaxel, ZEN003694, Talazoparib, Pembrolizumab, Sacituzumab Govitecan-hziy, Datopotamab Deruxtecan (Dato-DXd), and others.

 

Stay ahead with the most recent pipeline outlook for Triple Negative Breast Cancer. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Triple Negative Breast Cancer Treatment Drugs

 

Triple Negative Breast Cancer Emerging Drugs Profile

  • Camrelizumab: Jiangsu HengRui Medicine
  • SKB264: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
  • AK117: Akeso Biopharma
  • PLX038: ProLynx
  • PMD-026: Phoenix Molecular Designs

 

Explore groundbreaking therapies and clinical trials in the Triple Negative Breast Cancer Pipeline. Access DelveInsight’s detailed report now! @ New Triple Negative Breast Cancer Drugs

 

Triple Negative Breast Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration

  • Oral
  • Parenteral
  • intravenous
  • Subcutaneous
  • Topical.

 

Triple Negative Breast Cancer Products have been categorized under various Molecule types such as

  • Monoclonal Antibody
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy

 

Unveil the future of Triple Negative Breast Cancer Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight’s expert analysis @ Triple Negative Breast Cancer Market Drivers and Barriers

 

Scope of the Triple Negative Breast Cancer Pipeline Report

  • Coverage- Global
  • Triple Negative Breast Cancer Companies- Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 Therapeutics, Inc., Infinity Pharmaceuticals, HiberCell, Inc., Zenith Epigenetics, BioLite, Inc., Abbisko Therapeutics, Phoenix Molecular Designs, OncoTherapy Science, ModernaTX, Inc, and others.
  • Triple Negative Breast Cancer Pipeline Therapies- Nanosomal Docetaxel Lipid Suspension (75 mg/m2), Taxotere® (100 mg/m2), B013+Nab-Paclitaxel, ZEN003694, Talazoparib, Pembrolizumab, Sacituzumab Govitecan-hziy, Datopotamab Deruxtecan (Dato-DXd), and others.
  • Triple Negative Breast Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Triple Negative Breast Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

 

Get the latest on Triple Negative Breast Cancer Therapies and clinical trials. Download DelveInsight’s in-depth pipeline report today! @ Triple Negative Breast Cancer Companies, Key Products and Unmet Needs

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Triple Negative Breast Cancer: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Triple Negative Breast Cancer – DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. Camrelizumab: Jiangsu HengRui Medicine
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. AK117: Akeso Biopharma
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I)
  14. PMD-026: Phoenix Molecular Designs
  15. Drug profiles in the detailed report…..
  16. Inactive Products
  17. Triple Negative Breast Cancer Key Companies
  18. Triple Negative Breast Cancer Key Products
  19. Triple Negative Breast Cancer- Unmet Needs
  20. Triple Negative Breast Cancer- Market Drivers and Barriers
  21. Triple Negative Breast Cancer- Future Perspectives and Conclusion
  22. Triple Negative Breast Cancer Analyst Views
  23. Triple Negative Breast Cancer Key Companies
  24. Appendix

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Triple Negative Breast Cancer Clinical Trials, Treatment Drugs, Pipeline Insights, and Companies 2024

Depth Filtration Market worth $2.9 billion by 2025

“The report “Depth Filtration Market by Media Type (Cellulose, Activated Carbon), Product (Capsule, Sheet, Module), Application(Final Product Processing (Biologics), cell Clarification, Viral Clearance, Operation Scale (Manufacturing, Lab) – Global Forecast to 2025”
North America accounted for the largest share of the global depth filtration market, followed by Europe. The large share of the North American market is attributed to the increasing R&D investments in US and government funding and initiatives in Canada.

According to the new market research report “Depth Filtration Market by Media Type (Cellulose, Activated Carbon), Product (Capsule, Sheet, Module), Application(Final Product Processing (Biologics), cell Clarification, Viral Clearance, Operation Scale (Manufacturing, Lab) – Global Forecast to 2025″, published by MarketsandMarkets™, the global Depth Filtration Market is estimated to grow from USD 1.7 billion in 2019 to USD 2.9 billion by 2025, at a CAGR of 9.0% during the forecast period.

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143876285

Factors such as increasing the adoption of single-use technologies and focus on developing large-molecule biopharmaceuticals are likely to drive the depth filtration market.

Cartridge filters segment accounted for the largest share of the  market, by product

Based on the product, the depth filtration market is segmented into cartridge filters, capsule filters, filter modules, filter sheets, plate and frame filters, accessories, and other products (includes caps, pads, pods, syringes, bags, and discs). The cartridge filters segment accounted for the largest share of the global depth filtration market in 2019. This can be attributed to the high dirt-holding capacity and long service life of these products.

Diatomaceous Earth segment accounted for the largest share of the depth filtration market, by media type

Based on media, the depth filtration market is broadly segmented into diatomaceous earth (DE), activated carbon, cellulose, perlite, and other media (glass fibers, quartz, borosilicate, and resin binders). The DE filters segment accounted for the largest share of 41.3% of the global depth filtration market in 2018. The large share of this segment is attributed to the high-quality filtration offered by DE and its wide range of applications in the pharmaceutical and biopharmaceutical industry.

Final Product Processing was the largest application segment in the depth filtration market 

Based on the application, the depth filtration market is segmented into final product processing, cell clarification, raw material filtration, diagnostics, and viral clearance. The final product processing segment is further categorized as small-molecule processing and biologics processing. The raw material filtration market is further segmented into media & buffer filtration and bioburden testing. In 2019, the final product processing segment accounted for the largest share of the depth filtration market due to the, expansion in generics production and the demand for high-quality final products.

Get 10% Customization on this Research Report:https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=143876285

Manufacturing scale was the largest operation scale segment of the depth filtration market 

Based on the operation scale, the depth filtration market is segmented into manufacturing-scale, pilot-scale, and lab-scale depth filtration. The manufacturing-scale segment is the largest and fastest-growing segment of the depth filtration market. This can be attributed to the increasing R&D activities for the production of biologics.

North America was the largest regional market for depth filtration market i

In 2019, North America accounted for the largest share of the global depth filtration market, followed by Europe. The large share of the North American market is attributed to the increasing R&D investments in US and government funding and initiatives in Canada. The major companies operating in the global depth filtration market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), GE Healthcare (US), 3M (US), Parker Hannifin Corporation (US), Porvair Filtration Group (UK), ErtelAlsop (US), Amazon Filters Ltd. (UK), Meissner Filtration Products, Inc. (US), Donaldson Comany, Inc. (US), Eaton Corporation (Ireland), Saint-Gobain Performance Plastics (France), Clariance Technique (Australia), Repligen Corporation (US), Microfilt India Pvt. Ltd. (India), Graver Technologies (US), Gusmer Enterprises (US), Filtrox AG (Switzerland), Pure Process (UK), Membrane Solutions (US), Allied Filter Systems Ltd. (UK), Pentair (US), Membracon (UK), and Phenomenex (US)

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.prnewswire.com/news-releases/depth-filtration-market-worth-2-9-billion-by-2025–exclusive-report-by-marketsandmarkets-301041858.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Depth Filtration Market worth $2.9 billion by 2025